Bipolaricins A-I, Ophiobolin-Type Tetracyclic Sesterterpenes from a Phytopathogenic Bipolaris Sp. Fungus

Mengting Liu,Weiguang Sun,Ling Shen,Xincai Hao,Weaam Hasan Al Anbari,Shuang Lin,Huaqiang Li,Weixi Gao,Jianping Wang,Zhengxi Hu,Yonghui Zhang
DOI: https://doi.org/10.1021/acs.jnatprod.9b00744
IF: 5.1
2019-01-01
Journal of Natural Products
Abstract:A preliminary phytochemical investigation on the EtOAc extracts of the fungus Bipolaris sp. TJ403-B1 resulted in the identification of 12 ophiobolin-type phytotoxins (1-12), including nine new ones, termed bipolaricins A-I (1-9). The structures of 1-9 were elucidated via spectroscopic data (including HRESIMS and 1D and 2D NMR) and single-crystal X-ray diffraction (Cu K alpha) analyses. All of the isolated compounds were tested in terms of HMG-CoA reductase inhibitory, anti-inflammatory, and cytotoxic activities. Compound 10 showed HMG-CoA reductase inhibitory activity (IC50 = 8.4 +/- 0.4 mu M), and 2, 3, and 10-12 showed significant inhibitory potency against lipopolysaccharide (LPS)-induced nitric oxide production, with MIN IC50 values in the range of 5.1 +/- 0.3 to 20 +/- 1 mu M. Further experiments showed that 10 could significantly inhibit the production of IL-1 beta, RANTES, MIP-1 beta, and TNF-alpha as well as enhance the release of IL-13 in macrophages through the inhibition of HO-1 induction as well as the NF-kappa B pathway. These findings provide a scientific rationale for an anti-inflammatory therapeutic and a template for a new HMG-CoA reductase inhibitor to produce a potential anti-hyperlipidemia agent.
What problem does this paper attempt to address?